Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREV-IX_COMBO: Synflorix and Prevenar13 in High-risk Indigenous Infants
NCT01174849Phase 4Completed
- Sponsor
- Menzies School of Health Research
- Start
- Aug 2011
- Primary completion
- Sep 2017
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 10-valent pneumococcal conjugate vaccine, pneumococcal 13-valent conjugate vaccine in otitis media, sponsored by Menzies School of Health Research. Started Aug 2011; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccinepneumococcal 13-valent conjugate vaccine
03
Conditions
otitis media
Beyond the preview
Go deeper on NCT01174849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174849.